What to Expect When Starting Celecoxib
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.
Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.
Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.
See our Terms of Use and Editorial Policy.
Introduction
Celecoxib (Celebrex) is a selective COX-2 inhibitor NSAID used to treat osteoarthritis, rheumatoid arthritis, acute pain, and ankylosing spondylitis. Unlike traditional NSAIDs (ibuprofen, naproxen), celecoxib is more selective for the COX-2 enzyme involved in inflammation, resulting in less GI toxicity (fewer ulcers and GI bleeding). However, it carries cardiovascular risks similar to other NSAIDs.
Week-by-week timeline
Starting Pain Relief
Celecoxib provides anti-inflammatory and analgesic effects beginning within a few hours of the first dose. For acute pain (dental, surgical), full doses of 400 mg initially then 200 mg twice daily provide rapid relief. For chronic arthritis, 100-200 mg twice daily is the standard dose.
Establishing Effectiveness
For chronic conditions like osteoarthritis or rheumatoid arthritis, the full anti-inflammatory benefit develops over 1-2 weeks of consistent use. You should notice reduced joint stiffness, pain, and improved mobility. GI side effects are less common than with traditional NSAIDs.
Assessing Response
Evaluate pain control and function. If pain relief is inadequate, discuss dose adjustment with your prescriber. Blood pressure may increase slightly — celecoxib, like all NSAIDs, can raise blood pressure and may reduce effectiveness of antihypertensives.
Risk-Benefit Assessment
Your prescriber should periodically reassess whether celecoxib is still needed and at the lowest effective dose. Kidney function and blood pressure should be checked. Celecoxib is intended for use at the lowest effective dose for the shortest duration.
Long-Term Management
For chronic arthritis, long-term use may be necessary. Long-term risks include cardiovascular events, kidney problems, and GI complications (less than non-selective NSAIDs but not zero). Report any chest pain, leg swelling, or signs of GI bleeding promptly.
When to call your doctor
Contact your healthcare provider if you experience:
- Chest pain, shortness of breath, or sudden weakness (signs of heart attack or stroke — NSAIDs increase cardiovascular risk)
- Black, tarry, or bloody stools, or vomiting blood (GI bleeding)
- Significant swelling of feet or ankles (fluid retention)
- Decreased urine output or rapid weight gain (kidney problems)
- Severe skin reaction: blistering, peeling, red rash (Stevens-Johnson syndrome — rare but serious)
- Yellowing of skin or eyes (liver problems)
- Signs of allergic reaction: hives, facial swelling, difficulty breathing
Tips for getting started
Take celecoxib at the lowest effective dose for the shortest duration needed. If you have cardiovascular disease, discuss with your doctor whether celecoxib is appropriate — all NSAIDs increase CV risk. If you have a sulfonamide allergy, inform your prescriber (celecoxib contains a sulfonamide moiety). Take with food to reduce GI upset. Monitor blood pressure regularly. Avoid other NSAIDs while taking celecoxib. Tell all providers about celecoxib use before surgery or procedures.
Frequently asked questions
More about Celecoxib
References
- [Regulatory] FDA Label: Celebrex (celecoxib) Capsules https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020998s047lbl.pdf Accessed 2026-03-01.
- [Regulatory] NIH MedlinePlus: Celecoxib https://medlineplus.gov/druginfo/meds/a699022.html Accessed 2026-03-01.
- [Clinical] PRECISION Trial: Cardiovascular Safety of Celecoxib https://www.nejm.org/doi/10.1056/NEJMoa1611593 Accessed 2026-03-01.
Written and fact-checked by PrescriptionDrugs.org Editorial Team
Last updated: